Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaurav Varma

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The New England Journal of Medicine|April 12, 2013
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphomaKieron Dunleavy, Stefania Pittaluga, Lauren S Maeda, et al.
Leukemia & Lymphoma|January 5, 2025
Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysisGaurav Varma, Lindsay Fogel, Beth Gordon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple MyelomaEileen M Boyle, Patrick Blaney, James H Stoeckle, et al.
Blood|May 7, 2025
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypesDylan C Gagler, Hussein Ghamlouch, Di Zhang, et al.
The New England Journal of Medicine|April 9, 2015
Ibrutinib in previously treated Waldenström's macroglobulinemiaSteven P Treon, Christina K Tripsas, Kirsten Meid, et al.
Blood Advances|July 20, 2021
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysisJuan Pablo Alderuccio, Adam J Olszewski, Andrew M Evens, et al.
Haematologica|February 4, 2021
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort studyAdam S Zayac, Andrew M Evens, Alexey Danilov, et al.
Blood|July 15, 2020
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centersAndrew M Evens, Alexey Danilov, Deepa Jagadeesh, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The New England Journal of Medicine|April 12, 2013
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphomaKieron Dunleavy, Stefania Pittaluga, Lauren S Maeda, et al.
Leukemia & Lymphoma|January 5, 2025
Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysisGaurav Varma, Lindsay Fogel, Beth Gordon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple MyelomaEileen M Boyle, Patrick Blaney, James H Stoeckle, et al.
Blood|May 7, 2025
A multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypesDylan C Gagler, Hussein Ghamlouch, Di Zhang, et al.
The New England Journal of Medicine|April 9, 2015
Ibrutinib in previously treated Waldenström's macroglobulinemiaSteven P Treon, Christina K Tripsas, Kirsten Meid, et al.
Blood Advances|July 20, 2021
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysisJuan Pablo Alderuccio, Adam J Olszewski, Andrew M Evens, et al.
Haematologica|February 4, 2021
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort studyAdam S Zayac, Andrew M Evens, Alexey Danilov, et al.
Blood|July 15, 2020
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centersAndrew M Evens, Alexey Danilov, Deepa Jagadeesh, et al.
Pageof 2